C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy

C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy

Background: Definitive chemoradiotherapy (CRT) is the primary treatment for non-metastatic anal squamous cell carcinoma (ASCC). Despite favorable treatment outcomes in general, failure rates up to 40% occur in locally advanced disease. For treatment escalation or de-escalation strategies easily asse...

Full description

Bibliographic Details
Main Authors: Daniel Martin, Franz Rödel, Panagiotis Balermpas, Ria Winkelmann, Emmanouil Fokas, Claus Rödel
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Oncology
Subjects:
anal cancer
C-reactive protein
albumin
biomarker
disease-free survival
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01200/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01200/full

Similar Items